One of the most revolutionary tools in cutting-edge medicine is a molecular scalpel so precise that it can modify defective ...
When startup Pairwise launched Conscious Greens, a line of CRISPR-edited mustard greens, consumers got to experience ...
Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...
As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...
In May, a historic moment in science and medicine was captured in a single photo that circulated across news outlets ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
In the latest close session, CRISPR Therapeutics AG (CRSP) was down 6.54% at $68.29. The stock trailed the S&P 500, which registered a daily gain of 1.56%. On the other hand, the Dow registered a gain ...
The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human immune system is still “mind-blowing” for molecular biologist Joshua Modell of ...
The presentation will introduce the Company’s novel SyNTase gene editing technology and highlight its application in ...
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...
VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback